# PDS Biotechnology Corporation (PDSB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PDSB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -17.10M | $ -7.16B | $ 4.36M | $ -3.58M |
| 2025 | $ 0 | $ -35.32M | $ -28.42M | $ 16.93M | $ 9.25M |
| 2024 | $ 0 | $ -39.53M | $ -36.85M | $ 21.83M | $ 19.00M |
| 2023 | $ 0 | $ -46.43M | $ -36.37M | $ 23.85M | $ 26.13M |
| 2022 | $ 0 | $ -45.64M | $ -28.72M | $ 23.47M | $ 44.00M |
| 2021 | $ 0 | $ -20.11M | $ -14.84M | $ 490.4K | $ 63.21M |
| 2020 | $ 0 | $ -18.91M | $ -16.75M | $ 610.3K | $ 27.13M |
| 2019 | $ 0 | $ -9.03M | $ -23.33M | $ 0 | $ 11.70M |
| 2018 | $ 0 | $ -27.43M | $ -43.78M | $ 30.0K | $ 29.84M |
| 2017 | $ 0 | $ -68.51M | $ -55.08M | $ 20.46M | $ 62.37M |
| 2016 | $ 0 | $ -53.41M | $ -45.23M | $ 14.95M | $ 89.28M |
| 2015 | $ 0 | $ -39.42M | $ -32.37M | $ 5.30M | $ 122.48M |
| 2014 | $ 0 | $ -9.44M | $ -8.93M | $ 2.79M | $ -27.83M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | -1.22 |
| Liabilities / Eq | -3.46 |
| Current Ratio | 0.57 |

## Other views

- [Metrics](https://sponda.capital/en/PDSB.md)
- [Charts](https://sponda.capital/en/PDSB/charts.md)
- [Compare](https://sponda.capital/en/PDSB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.